172 related articles for article (PubMed ID: 15690125)
1. Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice.
Shen S; Khazaeli MB; Gillespie GY; Alvarez VL
J Neurooncol; 2005 Jan; 71(2):113-9. PubMed ID: 15690125
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601).
Mamelak AN; Jacoby DB
Expert Opin Drug Deliv; 2007 Mar; 4(2):175-86. PubMed ID: 17335414
[TBL] [Abstract][Full Text] [Related]
3. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
[TBL] [Abstract][Full Text] [Related]
5. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
Mamelak AN; Rosenfeld S; Bucholz R; Raubitschek A; Nabors LB; Fiveash JB; Shen S; Khazaeli MB; Colcher D; Liu A; Osman M; Guthrie B; Schade-Bijur S; Hablitz DM; Alvarez VL; Gonda MA
J Clin Oncol; 2006 Aug; 24(22):3644-50. PubMed ID: 16877732
[TBL] [Abstract][Full Text] [Related]
6. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
Lee Y; Bullard DE; Humphrey PA; Colapinto EV; Friedman HS; Zalutsky MR; Coleman RE; Bigner DD
Cancer Res; 1988 May; 48(10):2904-10. PubMed ID: 2452014
[TBL] [Abstract][Full Text] [Related]
7. Use of chlorotoxin for targeting of primary brain tumors.
Soroceanu L; Gillespie Y; Khazaeli MB; Sontheimer H
Cancer Res; 1998 Nov; 58(21):4871-9. PubMed ID: 9809993
[TBL] [Abstract][Full Text] [Related]
8. Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomas.
Zhao L; Zhu J; Cheng Y; Xiong Z; Tang Y; Guo L; Shi X; Zhao J
ACS Appl Mater Interfaces; 2015 Sep; 7(35):19798-808. PubMed ID: 26291070
[TBL] [Abstract][Full Text] [Related]
9. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
10. Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion.
Dardevet L; Rani D; Aziz TA; Bazin I; Sabatier JM; Fadl M; Brambilla E; De Waard M
Toxins (Basel); 2015 Mar; 7(4):1079-101. PubMed ID: 25826056
[TBL] [Abstract][Full Text] [Related]
11. Imaging glioma extent with 131I-TM-601.
Hockaday DC; Shen S; Fiveash J; Raubitschek A; Colcher D; Liu A; Alvarez V; Mamelak AN
J Nucl Med; 2005 Apr; 46(4):580-6. PubMed ID: 15809479
[TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis and Preliminary Biological Evaluation of
Zhao J; Wang YL; Li XB; Gao SY; Liu SY; Song YK; Wang JY; Xiong Y; Ma H; Jiang L; Yang ZY; Tang GH; Chu JP
Contrast Media Mol Imaging; 2018; 2018():8439162. PubMed ID: 30670934
[TBL] [Abstract][Full Text] [Related]
13. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
Gestin JF; Loussouarn A; Bardiès M; Gautherot E; Gruaz-Guyon A; Saï-Maurel C; Barbet J; Curtet C; Chatal JF; Faivre-Chauvet A
J Nucl Med; 2001 Jan; 42(1):146-53. PubMed ID: 11197965
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of SPECT imaging with 131I-labeled monoclonal antibody SZ39 in nude mice bearing human glioma xenografts.
Lan Q; Huang Q; Bao S
J Neuroimaging; 1996 Apr; 6(2):131-5. PubMed ID: 8634489
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody-targeted radiotherapy of renal cell carcinoma using a nude mouse model.
Chiou RK; Vessella RL; Limas C; Shafer RB; Elson MK; Arfman EW; Lange PH
Cancer; 1988 May; 61(9):1766-75. PubMed ID: 2451555
[TBL] [Abstract][Full Text] [Related]
16. Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results.
Reardon DA; Quinn JA; Akabani G; Coleman RE; Friedman AH; Friedman HS; Herndon JE; McLendon RE; Pegram CN; Provenzale JM; Dowell JM; Rich JN; Vredenburgh JJ; Desjardins A; Sampson JH; Gururangan S; Wong TZ; Badruddoja MA; Zhao XG; Bigner DD; Zalutsky MR
J Nucl Med; 2006 Jun; 47(6):912-8. PubMed ID: 16741299
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR
J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684
[TBL] [Abstract][Full Text] [Related]
18. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
[TBL] [Abstract][Full Text] [Related]
19. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
Schuster JM; Garg PK; Bigner DD; Zalutsky MR
Cancer Res; 1991 Aug; 51(16):4164-9. PubMed ID: 1714341
[TBL] [Abstract][Full Text] [Related]
20. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung.
Stein R; Goldenberg DM; Thorpe SR; Mattes MJ
J Nucl Med; 1997 Mar; 38(3):391-5. PubMed ID: 9074526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
